Antipsychotics Rarely Cause Persistent QTc Prolongation in Children and Adolescents

The clinical use of antipsychotic medications in children and adolescents has expanded significantly to manage a broad spectrum of neurodevelopmental and behavioral conditions [1, 2]. While these agents are effective for stabilizing severe symptoms, they are frequently associated with metabolic and cardiovascular concerns that complicate long-term management [3, 4]. Among these risks, the potential for drug-induced QTc prolongation (a delay in the heart's electrical recharging system that can predispose patients to arrhythmias) remains a primary focus of clinical anxiety due to its association with life-threatening ventricular events. Current practice often mandates rigorous electrocardiographic screening, yet the real-world incidence of clinically significant cardiac events in the pediatric population remains poorly defined [5]. A new study now offers data-driven insights into the frequency and persistence of these cardiac findings in a large naturalistic cohort of young patients.